WMSA
AXDX

Weiss Multi-Strategy Advisers’s Accelerate Diagnostics AXDX Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-1,100
Closed -$127K – 510
2018
Q4 		$127K Sell
1,100
-5
-0.5% -$741 0.01% 423
2018
Q3 		$254K Buy
1,105
+5
+0.5% +$1.1K 0.01% 486
2018
Q2 		$245K Buy
+1,100
New +$246K 0.01% 514

Other funds holding AXDX

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

Weiss Multi-Strategy Advisers's AXDX Position: Q1 2019 in Review

Weiss Multi-Strategy Advisers sold out of Accelerate Diagnostics (AXDX) in Q1 2019, closing a stake of 1,100 shares — an estimated $127K sold.

Weiss Multi-Strategy Advisers first reported a position in AXDX in Q2 2018 and held it in 3 quarters. The position peaked at $254K in Q3 2018. 114 funds tracked by Wall St. Rank hold AXDX as of Q1 2019.

  • Weiss Multi-Strategy Advisers reported no remaining Accelerate Diagnostics position as of Q1 2019 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 1,100 Accelerate Diagnostics shares in Q1 2019, an estimated $127K.
  • Weiss Multi-Strategy Advisers first reported a position in Accelerate Diagnostics in Q2 2018 and held it in 3 quarters.
  • Weiss Multi-Strategy Advisers's Accelerate Diagnostics position peaked at $254K in Q3 2018.
  • 114 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q1 2019.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2019, filed 15 May 2019.